Meet is an international talent provider to the life sciences sector.
Meet services clients across three core, high growth verticals: Pharma, Med-Tech and Healthcare Communications, and works with a broad range of blue-chip multinationals, as well as emerging start-ups.
The business currently employs 160 people across its offices in London, New York, San Francisco, San Diego and Berlin.
The investment was funded from NorthEdge Fund III, and was led by Managing Partner Ray Stenton, Director and Head of North West Phil Frame, Director Liam May and Investment Directors Kevin O’Loughlin and James Marshall. Ray Stenton and Phil Frame will join Meet’s board.
The life sciences sector generates £80bn turnover annually in the UK alone, and is expected to deliver double-digit year-on-year growth through to 2025.
The funding from NorthEdge will allow Meet to continue to invest in its people and grow its capacity to support the significant demand in the high-growth life sciences market. The business also plans to broaden its global office network and client base, as well as accelerating growth through M&A.
Hannah Donaldson said: “We are really proud of the business we’ve built. We have a diverse range of extremely talented people working with us, which has allowed us to grow the company at an impressive rate over the last few years – expanding globally and targeting new markets and customers.
“It was important to us that our private equity partner had the same vision and values as we do. NorthEdge places huge emphasis on people, culture and sustainability, which aligns with how we do things at Meet. This is a really exciting journey that we’re embarking on and we’re delighted to have a partner like NorthEdge on board.”
Ray Stenton said: “Meet has demonstrated that it has a deep understanding of the life sciences sector and has built an enviable client base as a result.
“The depth of their client relationships coupled with their ability to grow a globally successful business is testament to Hannah and her team’s impressive talent. We’re thrilled to have Meet join our growing portfolio of healthcare businesses and look forward to working alongside the team to continue to grow the business over the coming years.”